1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S279000, C514S183000, C546S112000

Reexamination Certificate

active

07928238

ABSTRACT:
The invention is directed to compounds of Formula (I) described herein useful as CETP inhibitors, compositions containing them, and methods of using them.

REFERENCES:
patent: 5580885 (1996-12-01), King et al.
patent: 5616537 (1997-04-01), Yokota et al.
patent: 5770544 (1998-06-01), Yokota et al.
patent: 6051601 (2000-04-01), Dombroski et al.
patent: 6093573 (2000-07-01), Beamer et al.
patent: 6262074 (2001-07-01), Otten et al.
patent: 6476075 (2002-11-01), Sikorski et al.
patent: 6479436 (2002-11-01), Otten et al.
patent: 6642228 (2003-11-01), Hayashi et al.
patent: 6713508 (2004-03-01), Sahoo et al.
patent: 7015219 (2006-03-01), Dickson et al.
patent: 7125891 (2006-10-01), Breslin et al.
patent: 2002/0013314 (2002-01-01), Zhu et al.
patent: 2003/0162777 (2003-08-01), Leonardi et al.
patent: 2003/0181446 (2003-09-01), Leonardi et al.
patent: 2004/0034089 (2004-02-01), Breslin et al.
patent: 2004/0039018 (2004-02-01), Ruggeri
patent: 2005/0113368 (2005-05-01), Bhuniya et al.
patent: 2006/0276509 (2006-12-01), Breslin et al.
patent: 0 198 264 (1986-03-01), None
patent: 0 801 060 (1997-03-01), None
patent: WO 93/05038 (1993-03-01), None
patent: WO 94/01415 (1994-01-01), None
patent: WO 96/11920 (1996-04-01), None
patent: WO 96/15099 (1996-05-01), None
patent: WO 98/12180 (1998-03-01), None
patent: WO 98/12192 (1998-03-01), None
patent: WO 00/78716 (2000-12-01), None
patent: WO 01/12187 (2001-02-01), None
patent: WO 01/57003 (2001-08-01), None
patent: WO 02/36116 (2002-05-01), None
patent: WO 03/031436 (2003-04-01), None
patent: WO 2004/037788 (2004-05-01), None
patent: WO 2004/072041 (2004-08-01), None
patent: WO 2004/072042 (2004-08-01), None
Hesler et al., J. Biol. Chem., 262:2275-2282, 1987.
Au-Young and Fielding, Proc. Natl. Acad. Sci., 89:4094-4098, 1992.
Bruce et al., Curr. Opin. Struct. Biol., 8:426-434, 1998.
Marcel et al., Journal of Clinical Investigation, 85:10-17, 1990.
McPherson et al., Arteriosclerosis and Thrombosis: A Jounral of Vascular Biology, 11(4):797-804, 1991.
Nishida et al., Journal of Biological Chemistry, 268(22):16352-60, 1993.
Guerin et al., Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 14(5):679-85, 1994.
Guerin et al., Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 14(2):199-206, 1994.
Packard and Shepard, ARterscler. Thromb. Vasc. Biol., 17:3542-3556, 1997.
Guerin et al., European Journal of Clinical Investigation, 26(6):485-94, 1996.
Guerin et al, Arterioscloerosis, Thrombosis and Vascular Biology, 20(1):189-97, 2001.
Sugano et al., Journal of Biological Chemistry, 273(9):5033-6, 1998.
Rittershaus et al., Arteriosclerosis, Thrombosis and Vascular Biology, 20(9) :2106-2112, 2000.
Whitlock et al., Journal of Cinical Investigation, 84(1) :129-37, 1989.
Okamoto et al., Nature, 406:203-207, 2000.
Huang et al., Clin. Sci., 103(6):587-594, 2002.
DeGrooth et al., Circulation, 105(18):2159-2165, 2002.
Brousseau et al., New England Journal of Medicine, 350(15) :1505-1515, 2004.
Berge et al., “Pharmaceutical Salts.”, J. Pharm.Sci., 1977, vol. 66(1), pp. 1-19.
Connolly et al., “Sterospecific Inhibition of CETP by ChiralN,N-Disubstituted Trifluoro-3-amino-2-propanols.”, Biochemistry, 2000, vol. 39, pp. 13870-13879.
Gould P.L., “Salt Selection for Basic Drugs.”, International J. Pharm., 1986, vol. 33, pp. 201-217.
Still et al., “Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution.”, J. Org. Chem., 1978, vol. 43(14), pp. 2923-2925.
Tashiro et al., “Preparation of Bromobenzoic Acids From the Corresponding Bromotoluenes Via the Krohke Method.”, Organic Preparations and Procedures International, 1984, vol. 16(5), pp. 379-383.
International Search Report, International U.S. Appl. No. PCT/US2007/068628, Date of Mailing of International Search Report, Apr. 28, 2008.
Written Opinion of International Search Authority relating to International Application No. PCT/US2007/068628, Date of Mailing of Written Opinion, Apr. 28, 2008.
Translation of EP0198264.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2619663

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.